EverSource Wealth Advisors LLC recently made a significant investment of $49,000 in ARK Genomic Revolution ETF (BATS:ARKG). This move demonstrates the firm’s confidence in the potential growth of the ETF. ARK Genomic Revolution ETF focuses on companies that are at the forefront of genomic research and development, making it an attractive option for investors looking to capitalize on advancements in this field.
Investing in ARK Genomic Revolution ETF aligns with EverSource Wealth Advisors LLC’s strategy of seeking out innovative and promising investment opportunities. By diversifying their portfolio with this ETF, the firm is positioning itself to benefit from the ongoing advancements in genomics and related technologies.
Overall, EverSource Wealth Advisors LLC’s investment in ARK Genomic Revolution ETF reflects their commitment to staying ahead of the curve and capitalizing on emerging trends in the market. This move reinforces the firm’s reputation as a forward-thinking and proactive investment advisor.